We take a look at directors buying and selling shares in their own company in our weekly column.
- CEO buys 10,000 shares in Aquis Exchange
- Foxtons Chairman buys shares
- Eckoh non-exec increases beneficial holding
- Interim CFO buys shares in Glantus
Here’s why Director Dealings can play an important role in stock-picking
CEO buys 10,000 shares in Aquis Exchange
Aquis Exchange LON:AQX CEO, Alasdair Haynes has purchased 10,000 shares in the company at a price of 390p for a total consideration of £39,000. His wife has purchased a further 2,000 shares, also at 390p per share. In addition, Non Executive Director Glenn Collinson has purchased 5,000 shares at 412p per share and a further 7,500 shares at 400p per share for a total consideration of £51,500. This follows impressive final results for the AIM listed next-generation marketplace last week that saw profit before tax up 27% with underlying profit soaring by 41%.
At the time of writing, shares were trading at 393p, up 3.4% for the year to date and -17% over the last 12 months.
Foxtons Chairman buys shares
Foxtons LON:FOXT Chairman, Nigel Rich has purchased 31,092 shares at a price of 40p per share for a total consideration of £12,437. The property lettings and sales business released final results last month that highlighted strong trading performance driven by significant growth in non-cyclical, recurring Lettings income and posted total revenue up 11% to £140.3m.
Shares were trading at 40.35p, up 33% this year and -12% over the last 12 months.
Eckoh non-exec increases beneficial holding
Eckoh AIM:ECK Non-Executive Director, David Coghlan has purchased a total of 125,000 shares at a price of 35.25 pence per share through Scawton Limited, a closely associated company, for a total consideration of £44,062, The AIM listed global provider of customer engagement security solutions released a strong set of interim results towards the end of last year with group revenue up 33% and in line with market expectations with CEO, Nik Philpot commenting: “These are a great set of results, showing the anticipated strong progress in key areas. I am particularly pleased with the increasing organic and overall levels of ARR and contracted orders. They reflect our organic growth, the successful integration of Syntec, strong growth in the key North American market, and the ongoing momentum from cloud deployments.”
Shares were trading at 33.65p today, down 18% for the year to date and -16% over the last 12 months.
- Data business booms as Aquis expands client base
- Five Biggest Aquis Stocks of 2024
- Three Quick Facts: Blue Star Capital, Next, Aquis
Interim CFO buys shares in Glantus
Glantus LON:GLAN Interim CFO and Executive Director, Diane Gray Smith purchased 100,000 shares at a price of 7p per share for a total consideration of £7,000. The AIM listed provider of Accounts Payable automation and analytics solutions issued 13m new shares last month and confirmed a debt refinancing to extend the repayment date of a €5 million loan repayment due in August 2023 by 12 months. This follows a trading update published earlier this year noting challenging conditions from its global restructuring which has impacted productivity, and a re-evaluation of expected revenue from two client contracts.
Shares were trading at 6.75p at the time of writing, down 27% for the year to date and -91% over the last 12 months.
